Final Results of the Prospective FH02 Mammographic Surveillance Study of Women Aged 35–39 at Increased Familial Risk of Breast Cancer-Reference-Cited by-同舟云学术

Final Results of the Prospective FH02 Mammographic Surveillance Study of Women Aged 35–39 at Increased Familial Risk of Breast Cancer

Published:2019-01 Issue: Volume:7 Page:39-46
ISSN:2589-5370
Container-title:EClinicalMedicine
language:en
Short-container-title:EClinicalMedicine

Author:

Evans D.G.,Thomas S.,Caunt J.,Burch A.,Brentnall A.R.,Roberts L.,Howell A.,Wilson M.,Fox R.,Hillier S.,Sibbering D.M.,Moss S.,Wallis M.G.,Eccles D.M.,Duffy S.

Funder

Breast Cancer Now

NIHR

CRUK

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. Mammographic surveillance in women aged 35–39 at enhanced familial risk of breast cancer (FH02);Evans;Familial Cancer,2014

2. Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer;Mackay;J Epidemiol Biostat,2001

3. The challenge of evaluating annual mammography screening for young women with a family history of breast cancer;J Med Screen,2006

4. Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study;Lancet Oncol,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast cancer incidence among women with a family history of breast cancer by relative's age at diagnosis;Cancer;2022-10-19

2. Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women;Breast Cancer Research and Treatment;2021-07-26

3. Long-Term Evaluation of Women Referred to a Breast Cancer Family History Clinic (Manchester UK 1987–2020);Cancers;2020-12-09

4. Screening and Selection: The Case of Mammograms;American Economic Review;2020-12-01

5. Sporadic implementation of UK familial mammographic surveillance guidelines 15 years after original publication;British Journal of Cancer;2019-11-25